ULK1 confers neuroprotection by regulating microglial/macrophages activation after ischemic stroke

Int Immunopharmacol. 2024 Jan 25:127:111379. doi: 10.1016/j.intimp.2023.111379. Epub 2023 Dec 22.

Abstract

Microglial activation and autophagy play a critical role in the progression of ischemic stroke and contribute to the regulation of neuroinflammation. Unc-51-like kinase 1 (ULK1) is the primary autophagy kinase involved in autophagosome formation. However, the impact of ULK1 on neuroprotection and microglial activation after ischemic stroke remains unclear. In this study, we established a photothrombotic stroke model, and administered SBI-0206965 (SBI), an ULK1 inhibitor, and LYN-1604 hydrochloride (LYN), an ULK1 agonist, to modulate ULK1 activity in vivo. We assessed sensorimotor deficits, neuronal apoptosis, and microglial/macrophage activation to evaluate the neurofunctional outcome. Immunofluorescence results revealed ULK1 was primarily localized in the microglia of the infarct area following ischemia. Upregulating ULK1 through LYN treatment significantly reduced infarct volume, improved motor function, promoted the increase of anti-inflammatory microglia. In conclusion, ULK1 facilitated neuronal repair and promoted the formation of anti-inflammatory microglia pathway after ischemic injury.

Keywords: Autophagy; Ischemic stroke; Microglia; Neuroinflammation; ULK1.

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Autophagy-Related Protein-1 Homolog / metabolism
  • Brain Ischemia* / drug therapy
  • Brain Ischemia* / metabolism
  • Humans
  • Infarction / metabolism
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Ischemic Stroke* / metabolism
  • Macrophage Activation
  • Macrophages / metabolism
  • Microglia / metabolism
  • Neuroprotection
  • Stroke* / drug therapy
  • Stroke* / metabolism

Substances

  • Autophagy-Related Protein-1 Homolog
  • Anti-Inflammatory Agents
  • ULK1 protein, human
  • Intracellular Signaling Peptides and Proteins